Rockwell Medical Q3 2026 net loss widens 33% year-over-year to $2.32 million
RMTI•Rockwell Medical’s third-quarter 2026 net loss widened 33% year over year to $2.32 million, while net sales rose 20% to $19.12 million and gross profit climbed 37% to $3.11 million.
1. Quarterly results
Rockwell Medical reported a third-quarter 2026 net loss of $2.32 million, up 33% year over year. Net sales increased 20% to $19.12 million, driven by greater purchases from existing customers and new customers in the western United States. Gross profit rose 37% to $3.11 million, primarily because of higher volumes.
2. Acquisition agreement
Following the quarter, Rockwell agreed to acquire Vantive’s global hemodialysis equipment, concentrates and related services business, including its manufacturing campus in Medolla, Italy.
